{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T02:14:10Z","timestamp":1791944050651,"version":"4.3.4"},"reference-count":38,"publisher":"American Society for Clinical Investigation","issue":"21","license":[{"start":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T00:00:00Z","timestamp":1762732800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Fondation Maladies Rares, AFM-T\u00e9l\u00e9thon","award":["#POCs(2023)-121503"],"award-info":[{"award-number":["#POCs(2023)-121503"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,10]]},"abstract":"<jats:p>Pulmonary arterial hypertension (PAH) is a rare and incurable disease characterized by progressive narrowing of pulmonary arteries (PA), resulting in right ventricular (RV) hypertrophy, RV failure, and eventually death. Orai1 inhibition has emerged as promising therapeutic approach to mitigate PAH. In this study, we investigated the efficacy of a clinically applicable selective Orai1 inhibitor, CM5480, and its effects when combined with standard PAH therapies in a preclinical PAH model. In male and female monocrotaline PAH-rats, CM5480 monotherapy improved hemodynamics, PA, and RV remodeling, as confirmed by RV catheterization, echocardiography, histology, and unbiased RNA-Seq. Standard PAH therapies, ambrisentan or sildenafil, achieved modest improvements in experimental PAH. In contrast, combination therapies with CM5480 yielded significantly greater benefits in reducing PA remodeling and improving cardiac function compared with monotherapies. Furthermore, in vitro experiments showed that Orai1 knockdown reduced pulmonary endothelial cell dysfunction in PAH and that the Orai1 pathway is independent of standard PAH-targeted pathways in PA smooth muscle cells (PASMCs). Finally, we found enhanced Orai1 expression\/function in PASMCs and pulmonary vein SMCs from patients with pulmonary veno-occlusive disease. These findings suggest that Orai1 inhibition represents a potentially novel and complementary therapeutic strategy for PAH by acting at pulmonary vascular and RV levels.<\/jats:p>","DOI":"10.1172\/jci.insight.191780","type":"journal-article","created":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T19:00:41Z","timestamp":1762714841000},"source":"Crossref","is-referenced-by-count":6,"title":["Combination of Orai1 inhibitor CM5480 with specific therapy mitigates pulmonary hypertension and its cardiac dysfunction"],"prefix":"10.1172","volume":"10","author":[{"given":"Ana\u00efs Saint-Martin","family":"Willer","sequence":"first","affiliation":[{"name":"Universit\u00e9 Paris-Saclay, INSERM, UMR_S 999, Hypertension Pulmonaire, Physiopathologie and Innovation Th\u00e9rapeutique (HPPIT), AP-HP, H\u00f4pital Bic\u00eatre, H\u00f4pital Marie Lannelongue (Groupe Hospitalier Paris Saint Joseph), FHU Andr\u00e9 Cournand, ERN-LUNG, Le Plessis-Robinson, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gr\u00e9goire","family":"Ruffenach","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris-Saclay, INSERM, UMR_S 999, Hypertension Pulmonaire, Physiopathologie and Innovation Th\u00e9rapeutique (HPPIT), AP-HP, H\u00f4pital Bic\u00eatre, H\u00f4pital Marie Lannelongue (Groupe Hospitalier Paris Saint Joseph), FHU Andr\u00e9 Cournand, ERN-LUNG, Le Plessis-Robinson, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bastien","family":"Masson","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris-Saclay, INSERM, UMR_S 999, Hypertension Pulmonaire, Physiopathologie and Innovation Th\u00e9rapeutique (HPPIT), AP-HP, H\u00f4pital Bic\u00eatre, H\u00f4pital Marie Lannelongue (Groupe Hospitalier Paris Saint Joseph), FHU Andr\u00e9 Cournand, ERN-LUNG, Le Plessis-Robinson, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristelle","family":"El Jekmek","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris-Saclay, INSERM, UMR_S 999, Hypertension Pulmonaire, Physiopathologie and Innovation Th\u00e9rapeutique (HPPIT), AP-HP, H\u00f4pital Bic\u00eatre, H\u00f4pital Marie Lannelongue (Groupe Hospitalier Paris Saint Joseph), FHU Andr\u00e9 Cournand, ERN-LUNG, Le Plessis-Robinson, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ang\u00e8le","family":"Bo\u00ebt","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris-Saclay, INSERM, UMR_S 999, Hypertension Pulmonaire, Physiopathologie and Innovation Th\u00e9rapeutique (HPPIT), AP-HP, H\u00f4pital Bic\u00eatre, H\u00f4pital Marie Lannelongue (Groupe Hospitalier Paris Saint Joseph), FHU Andr\u00e9 Cournand, ERN-LUNG, Le Plessis-Robinson, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Ad\u00e3o","sequence":"additional","affiliation":[{"name":"RISE-Health, Department of Surgery and Physiology, Faculty of Medicine, University of Porto, Alameda Prof. Hern\u00e2ni Monteiro, Portugal."},{"name":"Department of Pharmacology and Toxicology, School of Medicine, Universidad Complutense de Madrid, Madrid, Spain."},{"name":"CIBER Enfermedades Respiratorias (Ciberes), Madrid, Spain."},{"name":"Instituto de Investigaci\u00f3n Sanitaria Gregorio Mara\u00f1\u00f3n (IiSGM), Madrid, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"Gourmelon","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris-Saclay, INSERM, UMR_S 999, Hypertension Pulmonaire, Physiopathologie and Innovation Th\u00e9rapeutique (HPPIT), AP-HP, H\u00f4pital Bic\u00eatre, H\u00f4pital Marie Lannelongue (Groupe Hospitalier Paris Saint Joseph), FHU Andr\u00e9 Cournand, ERN-LUNG, Le Plessis-Robinson, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Beauvais","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris-Saclay, INSERM, UMR_S 999, Hypertension Pulmonaire, Physiopathologie and Innovation Th\u00e9rapeutique (HPPIT), AP-HP, H\u00f4pital Bic\u00eatre, H\u00f4pital Marie Lannelongue (Groupe Hospitalier Paris Saint Joseph), FHU Andr\u00e9 Cournand, ERN-LUNG, Le Plessis-Robinson, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Sabourin","sequence":"additional","affiliation":[{"name":"Inserm, UMR-S 1180, Signalisation et Physiopathologie Cardiovasculaire, Universit\u00e9 Paris-Saclay, Orsay, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Dutheil","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris-Saclay, INSERM, UMR_S 999, Hypertension Pulmonaire, Physiopathologie and Innovation Th\u00e9rapeutique (HPPIT), AP-HP, H\u00f4pital Bic\u00eatre, H\u00f4pital Marie Lannelongue (Groupe Hospitalier Paris Saint Joseph), FHU Andr\u00e9 Cournand, ERN-LUNG, Le Plessis-Robinson, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria-Rosa","family":"Ghigna","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris-Saclay, INSERM, UMR_S 999, Hypertension Pulmonaire, Physiopathologie and Innovation Th\u00e9rapeutique (HPPIT), AP-HP, H\u00f4pital Bic\u00eatre, H\u00f4pital Marie Lannelongue (Groupe Hospitalier Paris Saint Joseph), FHU Andr\u00e9 Cournand, ERN-LUNG, Le Plessis-Robinson, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Tesson","sequence":"additional","affiliation":[{"name":"INSERM, Nantes Universit\u00e9, CHU Nantes, Center for Research in Transplantation and Translational Immunology, UMR 1064, Nantes, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9verine","family":"M\u00e9noret","sequence":"additional","affiliation":[{"name":"INSERM, Nantes Universit\u00e9, CHU Nantes, Center for Research in Transplantation and Translational Immunology, UMR 1064, Nantes, France."},{"name":"Nantes Universit\u00e9, CHU Nantes, INSERM, CNRS, SFR Sant\u00e9, Inserm UMS 016 CNRS UMS 3556, Nantes, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Anegon","sequence":"additional","affiliation":[{"name":"INSERM, Nantes Universit\u00e9, CHU Nantes, Center for Research in Transplantation and Translational Immunology, UMR 1064, Nantes, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrice","family":"Bauer","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris-Saclay, INSERM, UMR_S 999, Hypertension Pulmonaire, Physiopathologie and Innovation Th\u00e9rapeutique (HPPIT), AP-HP, H\u00f4pital Bic\u00eatre, H\u00f4pital Marie Lannelongue (Groupe Hospitalier Paris Saint Joseph), FHU Andr\u00e9 Cournand, ERN-LUNG, Le Plessis-Robinson, France."},{"name":"Cardiology Department, Bic\u00eatre University Hospital, Le Kremlin-Bic\u00eatre, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"de Montpr\u00e9ville","sequence":"additional","affiliation":[{"name":"Department of Pathology, Groupe Hospitalier-Marie Lannelongue, Le Plessis-Robinson, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudarshan","family":"Hebbar","sequence":"additional","affiliation":[{"name":"CalciMedica Inc., La Jolla, California, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Br\u00e1s-Silva","sequence":"additional","affiliation":[{"name":"RISE-Health, Department of Surgery and Physiology, Faculty of Medicine, University of Porto, Alameda Prof. Hern\u00e2ni Monteiro, Portugal."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8090-4549","authenticated-orcid":true,"given":"Kenneth","family":"Stauderman","sequence":"additional","affiliation":[{"name":"CalciMedica Inc., La Jolla, California, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Humbert","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris-Saclay, INSERM, UMR_S 999, Hypertension Pulmonaire, Physiopathologie and Innovation Th\u00e9rapeutique (HPPIT), AP-HP, H\u00f4pital Bic\u00eatre, H\u00f4pital Marie Lannelongue (Groupe Hospitalier Paris Saint Joseph), FHU Andr\u00e9 Cournand, ERN-LUNG, Le Plessis-Robinson, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olaf","family":"Mercier","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris-Saclay, INSERM, UMR_S 999, Hypertension Pulmonaire, Physiopathologie and Innovation Th\u00e9rapeutique (HPPIT), AP-HP, H\u00f4pital Bic\u00eatre, H\u00f4pital Marie Lannelongue (Groupe Hospitalier Paris Saint Joseph), FHU Andr\u00e9 Cournand, ERN-LUNG, Le Plessis-Robinson, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9358-6922","authenticated-orcid":true,"given":"David","family":"Montani","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris-Saclay, INSERM, UMR_S 999, Hypertension Pulmonaire, Physiopathologie and Innovation Th\u00e9rapeutique (HPPIT), AP-HP, H\u00f4pital Bic\u00eatre, H\u00f4pital Marie Lannelongue (Groupe Hospitalier Paris Saint Joseph), FHU Andr\u00e9 Cournand, ERN-LUNG, Le Plessis-Robinson, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Capuano","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris-Saclay, INSERM, UMR_S 999, Hypertension Pulmonaire, Physiopathologie and Innovation Th\u00e9rapeutique (HPPIT), AP-HP, H\u00f4pital Bic\u00eatre, H\u00f4pital Marie Lannelongue (Groupe Hospitalier Paris Saint Joseph), FHU Andr\u00e9 Cournand, ERN-LUNG, Le Plessis-Robinson, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrice","family":"Antigny","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris-Saclay, INSERM, UMR_S 999, Hypertension Pulmonaire, Physiopathologie and Innovation Th\u00e9rapeutique (HPPIT), AP-HP, H\u00f4pital Bic\u00eatre, H\u00f4pital Marie Lannelongue (Groupe Hospitalier Paris Saint Joseph), FHU Andr\u00e9 Cournand, ERN-LUNG, Le Plessis-Robinson, France."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"232","published-online":{"date-parts":[[2025,11,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00879-2022"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01324-2024"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01424-2024"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01900-2018"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvz308"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.yjmcc.2018.04.003"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.122.321041"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.118.038891"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0330-2020"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/ng1180"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0506580102"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1002\/pro.4218"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btn615"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.122.19207"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M115.693911"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(16)30438-6"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2213558"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01347-2022"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-020-03220-x"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-022-03964-8"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1097\/MPA.0000000000001793"},{"key":"B22","unstructured":"CalciMedica, Inc. A Study of Auxora in Patients With AKI and Injurious Lung \u201cCrosstalk\u201d (KOURAGE). http:\/\/clinicaltrials.gov. NCT06374797. Accessed September 22, 2025"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-9-361"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.115.305464"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000012754.72951.3D"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00400.2024"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.124.012293"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2023-0015OC"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2024-0214ED"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.111.300220"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M114.625822"},{"key":"B32","unstructured":"CalciMedica, Inc. A Study of Auxora in Patients With Acute Pancreatitis and Accompanying SIRS (CARPO). http:\/\/clinicaltrials.gov. NCT04681066. Accessed September 22, 2025"},{"key":"B33","unstructured":"Rhizen Pharmaceuticals SA. Safety, Tolerability and Pharmacokinetics of Oral Doses of RP3128 of Rhizen Pharmaceuticals. http:\/\/clinicaltrials.gov. NCT02958982. Accessed September 22, 2025"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.ceca.2018.07.005"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1126\/science.1127883"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2017.09.022"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00612-2023"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3390\/biom11121781"}],"container-title":["JCI Insight"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/insight.jci.org\/articles\/view\/191780\/files\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T14:59:40Z","timestamp":1779029980000},"score":1,"resource":{"primary":{"URL":"https:\/\/insight.jci.org\/articles\/view\/191780"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,10]]},"references-count":38,"journal-issue":{"issue":"21","published-online":{"date-parts":[[2025,11,10]]},"published-print":{"date-parts":[[2025,11,10]]}},"alternative-id":["10.1172\/jci.insight.191780"],"URL":"https:\/\/doi.org\/10.1172\/jci.insight.191780","relation":{},"ISSN":["2379-3708"],"issn-type":[{"value":"2379-3708","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,10]]},"article-number":"e191780"}}